A fast uptake of nanoparticles (NPs) targeting mHsp70 is enabled since, compared to other tumor biomarkers such as HER-2, the turn-over rate of membrane-bound Hsp70 into the cytosol is rapid (minute range) [15]. This evidence concerns the gene HSPA1A and neoplasm.